EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Multifaceted Functions of Prion Protein (PrPC) in Cancer

Roland Abi Nahed iD, Hasan Safwan-Zaiter, Kevin Gemy, Camille Lyko, Mélanie Boudaud, Morgane Desseux, Christel Marquette iD, Tiphaine Barjat iD, Nadia Alfaidy iD, Mohamed Benharouga iD

Cancers · 13.10.2023 · 15 (20) · 4982

DOI: 10.3390/cancers15204982 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.10.2023. Verfasst von Roland Abi Nahed und 9 weiteren Autor:innen. Beteiligte Einrichtung: U1292, Laboratoire de BioSanté, Institut National de la Santé et de la Recherche Médicale (INSERM), F-38058 Grenoble, France. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale (INSERM), University Grenoble-Alpes, VALO-GRAL CBH-EUR-GS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cellular prion protein (PrPC) is a glycoprotein anchored to the cell surface by glycosylphosphatidylinositol (GPI). PrPC is expressed both in the brain and in peripheral tissues. Investigations on PrPC’s functions revealed its direct involvement in neurodegenerative and prion diseases, as well as in various physiological processes such as anti-oxidative functions, copper homeostasis, trans-membrane signaling, and cell adhesion. Recent findings have revealed the ectopic expression of PrPC in various cancers including gastric, melanoma, breast, colorectal, pancreatic, as well as rare cancers, where PrPC promotes cellular migration and invasion, tumor growth, and metastasis. Through its downstream signaling, PrPC has also been reported to be involved in resistance to chemotherapy and tumor cell apoptosis. This review summarizes the variance of expression of PrPC in different types of cancers and discusses its roles in their development and progression, as well as its use as a potential target to treat such cancers.

Schlagwörter

Stichwörter der Autor:innen

cancerdrug resistanceprion protein (PrPC)therapeutic target

Autor:innen und Institutionen

  • U1292, Laboratoire de BioSanté, Institut National de la Santé et de la Recherche Médicale (INSERM), F-38058 Grenoble, France.
  • Commissariat à l'Energie Atomique (CEA), DSV-IRIG, F-38054 Grenoble, France.
  • University of Grenoble Alpes (UGA), F-38058 Grenoble, France.

ORCID-Profile: Roland Abi Nahed, Christel Marquette, Tiphaine Barjat, Nadia Alfaidy, Mohamed Benharouga

Förderung

  • Institut National de la Santé et de la Recherche Médicale (INSERM)
  • University Grenoble-Alpes
  • VALO-GRAL CBH-EUR-GS
  • Région Auvergne-Rhône-Alpes/Cancéropôle Lyon Au-vergne Rhône-Alpes
  • Ligues Départementales (Isère & Savoie) contre le Cancer
  • ARC (association de recherche contre le cancer)
  • Fondation pour la Recherche Médicale (FRM)
  • GRAL, a program of the Chemistry Biology Health Graduate School of Université Grenoble Alpes

Zitieren

APA

Abi Nahed, R., Safwan-Zaiter, H., Gemy, K., Lyko, C., Boudaud, M., Desseux, M., Marquette, C., Barjat, T., Alfaidy, N., & Benharouga, M. (2023). The Multifaceted Functions of Prion Protein (PrPC) in Cancer. Cancers, 15(20), 4982. https://doi.org/10.3390/cancers15204982

Vancouver

Abi Nahed R, Safwan-Zaiter H, Gemy K, Lyko C, Boudaud M, Desseux M, et al. The Multifaceted Functions of Prion Protein (PrPC) in Cancer. Cancers. 2023;15(20):4982. doi:10.3390/cancers15204982

BibTeX
@article{AbiNahed2023,
  author = {Abi Nahed, Roland and Safwan-Zaiter, Hasan and Gemy, Kevin and Lyko, Camille and Boudaud, Mélanie and Desseux, Morgane and Marquette, Christel and Barjat, Tiphaine and Alfaidy, Nadia and Benharouga, Mohamed},
  title = {The Multifaceted Functions of Prion Protein (PrPC) in Cancer},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {20},
  pages = {4982},
  doi = {10.3390/cancers15204982}
}
Kostenlos starten →